Nervorum LLC

Findings

Discoveries at the intersection of cognition, design, and therapeutic innovation

In Progress NRV-019

Indalarium

Pharmacology Patent

Patent claims for novel compounds targeting therapeutic use in Parkinson's disease

Stage: Legal Process

Read
In Progress NRV-011

L-Theafetamine

Novel Pharmacutical

Patent claims for prodrug targeting therapeutic use in attention-deficit/hyperactivity disorders.

Stage:Development

Read
In Progress NRV-002

Xanthamine

Drug Discovery

Discovered New Stimulant Class/Scaffold consisting of a Xanthine Backbone and an Amphetamine Moiety, Results Computational

Stage: Development

Read

"To Invent, is to unlearn"